We are live on ! Find out more
ECM

Endurant Capital Management Portfolio holdings

AUM $17.4M
1-Year Est. Return 7.38%
This Fund
S&P 500
This Quarter Est. Return
+4.37%
1 Year Est. Return
+7.38%
3 Year Est. Return
+18.38%
5 Year Est. Return
+100.61%
10 Year Est. Return
–
AUM
$338M
AUM Growth
-$1.49B
Cap. Flow
-$1.49B
Cap. Flow %
-440.09%
Top 10 Hldgs %
50.11%
Holding
82
New
26
Increased
20
Reduced
13
Closed
22

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$21.3M
2
IART icon
Integra LifeSciences
IART
+$13.4M
3
ABBV icon
AbbVie
ABBV
+$12.8M
4
AHCO icon
AdaptHealth
AHCO
+$9.39M
5
EHC icon
Encompass Health
EHC
+$8.7M

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$6.95M
2
ICUI icon
ICU Medical
ICUI
+$6.55M
3
LH icon
Labcorp
LH
+$6.3M
4
CNC icon
Centene
CNC
+$5.94M
5
SIBN icon
SI-BONE Inc
SIBN
+$5.57M

Sector Composition

Rank Sector Weight
1 Healthcare 83.24%
2 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALXN
76
DELISTED
Alexion Pharmaceuticals
ALXN
– –
-4,148
Closed -$466K
HMSY
77
DELISTED
HMS Holdings Corp.
HMSY
– –
-161,914
Closed -$5.24M
PRNB
78
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
– –
-30,395
Closed -$1.82M
GNCA
79
DELISTED
Genocea Biosciences, Inc.
GNCA
– –
-119,979
Closed -$276K
ZGNX
80
DELISTED
Zogenix, Inc.
ZGNX
– –
-29,575
Closed -$799K
1 2 3
4

Similar funds

VAFP
Vahanian & Associates Financial Planning Saratoga Springs, New York $25.3M AUM 39.42% 1-Year Est. Return
CA
Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return
SCM
Somerset Capital Management London, United Kingdom $8.12M AUM 21.3% 1-Year Est. Return
FWM
Fiat Wealth Management Wayzata, Minnesota $7.9M AUM
TOPU
Trustees of Princeton University Princeton, New Jersey $7.77M AUM
CCMU
Cheyne Capital Management (UK) London, United Kingdom $27.9M AUM 36.14% 1-Year Est. Return
TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
HSCU
Half Sky Capital (UK) London, United Kingdom $30.5M AUM 67.32% 1-Year Est. Return

Endurant Capital Management's Q3 2020 Portfolio in Review

As of Q3 2020, Endurant Capital Management held 82 positions worth $338M, down 81% from $1.82B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Endurant Capital Management withdrew a net $1.49B in Q3 2020, closing 22 positions and reducing 13 holdings. Its most notable exit was Medtronic, an estimated $6.95M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 83% of assets, up from 12% a quarter earlier, followed by Industrials.

Against the trend, Endurant Capital Management opened a new position in Integra LifeSciences worth $13.3M.

  • Endurant Capital Management's largest Q3 2020 buy was Integra LifeSciences: 281,608 shares worth $13.3M.
  • Endurant Capital Management added most to Bristol-Myers Squibb in Q3 2020, an estimated $21.3M increase.
  • Endurant Capital Management's biggest Q3 2020 reduction was Centene, cutting an estimated $5.94M.
  • Endurant Capital Management fully exited Medtronic in Q3 2020, selling an estimated $6.95M.
  • Endurant Capital Management's ten largest holdings make up 50% of its $338M portfolio in Q3 2020.
  • Endurant Capital Management opened 26 new positions and closed 22 in Q3 2020.
  • Endurant Capital Management's portfolio value fell 81% quarter-over-quarter to $338M.

Based on Endurant Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.